the aid library

LIST OPTIONS

Filter

5994

Sort by:

Direction:

Download (198)

View PDF (303)

Public–private mix for TB prevention and care: a roadmap

World Health Organization WHO (2018) C_WHO

In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i... more

Download (444)

View PDF (1504)

WHO Regional strategic plan for EVD operational readiness and preparedness in countries neighboring the Democratic Republic of the Congo June 2018 – February 2019
recommended

World Health Organization WHO (2018) C_WHO

The Strategic plan aims to ensure alignment of preparedness and readiness actions in the nine countries focusing on eight technical areas: strengthening multisectoral coordination; surveillance for early detection; laboratory diagnostic capacity; points of entry; rapid response teams; risk communica... more

Download (379)

View PDF (328)

WHO report on cancer: setting priorities, investing wisely and providing care for all

World Health Organization WHO (2020) C1

Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report. In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available... more

Download (61)

View PDF (511)

Missed Opportunities for Early Access to Care of HIV-Infected Infants in Burkina Faso

Coulibaly M., N. Meda, C. Yonaba et al. PLOS ONE (2014) C2

The World Health Organization (WHO) has recommended a universal antiretroviral therapy (ART) for all HIVinfected children before the age of two since 2010, but this implies an early identification of these infants. We described the Prevention of Mother-to-Child HIV Transmission (PMTCT) cascade, the ... more

Download (253)

View PDF (171)

Handbook for public health capacity-building at ground crossings and cross-border collaboration

World Health Organization WHO (2020) C1

This handbook follows a comprehensive approach to health system strengthening at borders in order to support IHR national focal points and other national agencies in developing and implementing evidence-based action plans for IHR capacity development at ground crossings. The approach includes the mo... more

Download (125)

View PDF (130)

COVID-19: How to include marginalized and vulnerable people in risk communication and community engagement

Inter-Agency Standing Committee IASC; World Health Organization (WHO); UNICEF; et al. (2020) C1

Women, the elderly, adolescents, youth, and children, persons with disabilities, indigenous populations, refugees, migrants, and minorities experience the highest degree of socio-economic marginalization. Marginalized people become even more vulnerable in emergencies.1 This is due to factors su... more

Download (182)

View PDF (233)

Emergency medical teams: minimum technical standards and recommendations for rehabilitation

World Health Organization WHO; Handicap International, CBM; et al. (2016) C_WHO

his document, a first of its kind, clearly sets out the standards for rehabilitation and provides guidance on building or strengthening the capacity of EMTs in this area.The importance of early rehabilitation for functional outcomes is well documented. Rehabilitation needs can pe... more

Download (234)

View PDF (270)

Compendium of WHO and other UN guidance on health and environment
recommended

World Health Organization WHO; UN Environment; UNICEF (2021) C_WHO

Almost 25% of deaths worldwide could be prevented if the actions in the compendium were fully implemented This compendium provides a systematic compilation of published guidance from WHO and other UN organizations on health and environment. Guidance on policies and actions as well as awareness rais... more

Download (72)

View PDF (132)

Containment strategies: lessons from early COVID-19 responses in five African countries

World Health Organization WHO, Regional Office of Africa; AHOP WHO Regional Office for Africa (2021) C_WHO

The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises questions on the future of the response to COVID-19. Prevention remains the key strategy in most sub-Sa... more

Download (117)

View PDF (142)

Global roadmap for research and development of tuberculosis vaccines

European & Developing Countries Clinical Trials Partnership EDCTTP; Amterdam Institute for Global health & Development aighd (2021) C1

The roadmap describes the actions needed to achieve the three development goals for TB vaccines set by the WHO: 1. A safe, effective and affordable TB vaccine for adolescents and adults. 2. An affordable TB vaccine for neonates and infants with improved safety and efficacy. 3. A therapeutic v... more

Download (151)

View PDF (183)

Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended

World Health Organization (WHO) (2022) C_WHO

The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ... more

Download (126)

View PDF (166)

2021 Antibacterial agents in clinical and preclinical development: an overview and analysis

World Health Organization WHO (2022) C_WHO

This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent... more

Download (86)

View PDF (338)

Training and deployment of Key Informants (KIs) for case finding for children with severe visual impairment and blindness and Improving the follow up of children after cataract and other surgeries

Kilimanjaro Centre for Community Ophthalmology KCCO (2022) CC

The WHO estimates that 19 million children aged 15 years or younger are visually impaired. Of these, 1.4 million are irreversibly blind and need visual rehabilitation interventions for full psychological and personal development. The remainder have visual problems that could be prevented or treated.... more

Download (159)

View PDF (162)

Regional action framework for noncommunicable disease prevention and control in the Western Pacific

World Health Organisation (WHO) (2023) C_WHO

The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (‎NCD)‎ epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination... more

Download (96)

View PDF (111)

The role of HIV viral suppression in improving individual health and reducing transmission

World Health Organisation (WHO) (2023) C_WHO

This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol... more

Download (191)

View PDF (178)

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more

Download (16)

View PDF (16)

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector... more

Download (37)

View PDF (28)

Hypertension in adults: diagnosis and management

the National Institute for Health and Care Excellence (NICE) the National Institute for Health and Care Excellence (NICE) (2023) CC

The NICE guideline "Hypertension in Adults: Diagnosis and Management" outlines recommendations for diagnosing and managing hypertension in adults over 18, including those with type 2 diabetes. It emphasizes accurate blood pressure measurement, recommending ambulatory or home monitoring to confirm di... more

Download (14)

View PDF (15)

Improving the global diagnosis and management of asthma in children

Lenney, W.; Bush, A.; Fitzgerald, D.A. et al. BMJ Journals (2018) CC

Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee... more

Download (11)

View PDF (12)

Dolutegravir Resistance in Malawi’s National HIV Treatment Program

van Ossterhout, J. J.; Chipungu, C.; Nkhoma, L. et all. (2022) CC2

Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ... more

WHO Regional strategic plan for EVD operational readiness and preparedness in countries neighboring the Democratic Republic of the Congo June 2018 – February 2019 recommended

Compendium of WHO and other UN guidance on health and environment recommended

Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022 recommended

WHO Regional strategic plan for EVD operational readiness and preparedness in countries neighboring the Democratic Republic of the Congo June 2018 – February 2019
recommended

Compendium of WHO and other UN guidance on health and environment
recommended

Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended